-
Views
-
Cite
Cite
Andreas Eicken, Peter Ewert, Alfred Hager, Bjoern Peters, Sohrab Fratz, Titus Kuehne, Raymonde Busch, John Hess, Felix Berger, Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients, European Heart Journal, Volume 32, Issue 10, May 2011, Pages 1260–1265, https://doi.org/10.1093/eurheartj/ehq520
- Share Icon Share
Abstract
Dysfunction of valved conduits in the right ventricular outflow tract (RVOT) limits durability and enforces repeated surgical interventions. We report on our combined two-centre experience with percutaneous pulmonary valve implantation (PPVI).
One hundred and two patients with RVOT dysfunction [median weight: 63 kg (54.2–75.9 kg), median age: 21.5 years (16.2–30.1 years), diagnoses: TOF/PA 61, TAC 14, TGA 9, other 10, AoS post-Ross-OP 8] were scheduled for PPVI since December 2006. Percutaneous pulmonary valve implantation was performed in all patients. Pre-stenting of the RVOT was done in 97 patients (95%). The median peak systolic RVOT gradient decreased from 37 mmHg (29–46 mmHg) to 14 mmHg (9–17 mmHg, P < 0.001) and the ratio RV pressure/AoP decreased from 62% (53–76%) to 36% (30–42%, P < 0.0001). The median end-diastolic RV-volume index (MRI) decreased from 106 mL/m2 (93–133 mL/m2) to 90 mL/m2 (71–108 mL/m2, P = 0.001). Pulmonary regurgitation was significantly reduced in all patients. One patient died due to compression of the left coronary artery. The incidence of stent fractures was 5 of 102 (5%). During follow-up [median: 352 days (99–390 days)] one percutaneous valve had to be removed surgically 6 months after implantation due to bacterial endocarditis. In 8 of 102 patients, a repeated dilatation of the valve was done due to a significant residual systolic pressure gradient, which resulted in a valve-in-valve procedure in four.
This study shows that PPVI is feasible and it improves the haemodynamics in a selected patient collective. Apart from one coronary compression, the rate of complications at short-term follow-up was low. Percutaneous pulmonary valve implantation can be performed by experienced interventionalists with similar results as originally published. The intervention is technically challenging and longer clinical follow-up is needed.